• Mar 28, 2025

2 Reasons EHC is Risky and 1 Stock to Buy Instead

Encompass Health currently trades at $100.30 per share and has shown little upside over the past six months, posting a middling return of 3.8%. However, the stock is beating the S&P 500’s 1.4% decline during that period.

  • Mar 28, 2025

3 Reasons to Avoid ALGN and 1 Stock to Buy Instead

Align Technology has gotten torched over the last six months - since September 2024, its stock price has dropped 35.3% to $164.50 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

  • Mar 28, 2025

3 Reasons to Sell MATW and 1 Stock to Buy Instead

Although the S&P 500 is down 1.4% over the past six months, Matthews’s stock price has fallen further to $21.21, losing shareholders 8.6% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.